Search results for "030227 psychiatry"

showing 10 items of 1017 documents

Duration of euthymia and predominant polarity in bipolar disorder.

2018

The concept of Predominant Polarity (PP) provides relevant information for clinical practice and has been widely described as course specifier for Bipolar Disorder (BD), however it has not been incorporated in DSM-5 yet. A descriptive study was conducted to identify clinical patterns associated with PP in outpatients attending a Mental Health Unit.Clinical and socio-demographic characteristics were assessed from a sample of 118 euthymic outpatients fulfilling DSM 5 criteria for BDI or II recruited at a catchment area. According to their PP, patients were divided into three subgroups: depressive (DPP; 39.0%), manic (MPP; 32.2%) or indeterminate (IPP; 28.8%). Subgroups of PP were compared reg…

AdultMalemedicine.medical_specialtyBipolar DisorderTime FactorsCross-sectional studyPolarity (physics)DSM-503 medical and health sciences0302 clinical medicineInternal medicinemedicineHumansBipolar disorderDepression (differential diagnoses)Demographybusiness.industryMiddle Agedmedicine.diseaseMental healthCyclothymic Disorder030227 psychiatryDiagnostic and Statistical Manual of Mental DisordersHospitalizationPsychiatry and Mental healthClinical PsychologyCross-Sectional StudiesMental HealthPsychotic DisordersSample size determinationFemalemedicine.symptombusinessMania030217 neurology & neurosurgeryJournal of affective disorders
researchProduct

Do patients with bipolar disorder and subsyndromal symptoms benefit from functional remediation? A 12-month follow-up study

2016

We analyzed the efficacy of functional remediation, in a sample of patients with bipolar disorder who presented with subsyndromal symptoms. From a total sample of 239 patients with bipolar I and II disorder, according to DSM-IV-TR diagnostic criteria, entering a randomized clinical trial, those patients who presented with subsyndromal symptoms were selected based on a method already described by Berk and colleagues was applied. It consists of using the Clinical Global Impression-Bipolar version (CGI-BP) to establish the scores of the Hamilton Depression Rating Scale (HAM-D) and of the Young Mania Rating Scale (YMRS) that correspond with 1 in the CGI-BP. Functional outcome and mood symptoms …

AdultMalemedicine.medical_specialtyBipolar Disordermedicine.medical_treatmentYoung Mania Rating Scalelaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled trialRating scalelawmental disordersmedicinePsychoeducationHumansPharmacology (medical)Bipolar disorderBiological PsychiatryDepression (differential diagnoses)Psychiatric Status Rating ScalesPharmacologyAnalysis of VarianceChi-Square DistributionMiddle Agedmedicine.diseaseCognitive Remediation030227 psychiatryPsychotherapyPsychiatry and Mental healthTreatment OutcomeMoodNeurologyPhysical therapyFemaleNeurology (clinical)PsychologyPsychosocial030217 neurology & neurosurgeryFollow-Up StudiesClinical psychologyEuropean Neuropsychopharmacology
researchProduct

Dysfunctional decision-making related to white matter alterations in bipolar I disorder.

2015

Abstract Objective This study investigated how frontal white matter (WM) alterations in patients with bipolar I disorder (BD-I) are linked to motivational dysregulation, often reported in the form of risk-taking and impulsivity, and whether structure–function relations in patients might differ from healthy subjects (HC). Method We acquired diffusion data from 24 euthymic BD-I patients and 24 controls, to evaluate WM integrity of selected frontal tracts. Risk-taking was assessed by the Cambridge Gambling Task and impulsivity by self-report with the Barratt-Impulsiveness Scale. Results BD-I patients displayed significantly lower integrity in the right cingulum compared to HC. They also showed…

AdultMalemedicine.medical_specialtyBipolar I disorderBipolar DisorderDecision MakingAudiologyImpulsivityWhite matter03 medical and health sciences0302 clinical medicineRisk-TakingFasciculusmedicineCingulum (brain)HumansBipolar disorderPsychiatrybiologyAlcohol dependenceCase-control studyMiddle Agedbiology.organism_classificationmedicine.diseaseWhite Matter030227 psychiatryPsychiatry and Mental healthClinical Psychologymedicine.anatomical_structureCase-Control StudiesImpulsive BehaviorFemaleSelf Reportmedicine.symptomNerve NetPsychology030217 neurology & neurosurgeryJournal of affective disorders
researchProduct

A combined marker of early non-improvement and the occurrence of melancholic features improve the treatment prediction in patients with Major Depress…

2017

Abstract Background Early Improvement of depressive symptoms within two weeks of antidepressant treatment is a highly sensitive but less specific predictor of later treatment outcome. The aim of this study was to identify clinical features at treatment initiation which are associated with early improvement and non-improvement as well as to identify variables predicting non-remission in patients showing an early improvement. Methods 889 patients with a major depressive episode according to DSM-IV who had participated in an antidepressant treatment trial served as study sample. Clinical predictors (demographic variables, psychopathology, comorbid disorders) were analysed in 698 (79%) early im…

AdultMalemedicine.medical_specialtyComorbidityAvoidant personality disorderPatient ReadmissionSeverity of Illness IndexSuicidal Ideation03 medical and health sciences0302 clinical medicineRisk FactorsRating scaleInternal medicinemedicineHumansMajor depressive episodePsychiatryAtypical depressionDepression (differential diagnoses)Depressive Disorder Majorbusiness.industryMiddle Agedmedicine.diseaseAntidepressive Agents030227 psychiatryPsychiatry and Mental healthClinical PsychologyTreatment OutcomeMajor depressive disorderAntidepressantFemalemedicine.symptombusiness030217 neurology & neurosurgeryPsychopathologyJournal of Affective Disorders
researchProduct

Body mass index (BMI) in major depressive disorder and its effects on depressive symptomatology and antidepressant response

2019

Obesity is one of the most prevalent somatic comorbidities of Major Depressive Disorder (MDD). We aimed to investigate the relationship between body mass index (BMI) and MDD, the symptomatology of the disorder as well as the outcome of antidepressant treatment.Early medication change (EMC) trial participants with BMI measurement (n = 811) were categorized according to WHO-criteria in normal or low weight (BMI  25), overweight (25- 30), and obese (≥30). Depression severity and BMI was assessed in weekly intervals up to 8 weeks. BMI at baseline and course of BMI during the study were investigated in linear regression models as possible moderators of therapy response. Possible moderators such …

AdultMalemedicine.medical_specialtyComorbidityOverweightWeight GainBody Mass IndexDepressive symptomatology03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumansObesityDepression (differential diagnoses)Depressive Disorder Majorbusiness.industryMiddle Agedmedicine.diseaseObesityAntidepressive Agents030227 psychiatryPsychiatry and Mental healthClinical PsychologyAntidepressantMajor depressive disorderFemalemedicine.symptombusinessWeight gainBody mass index030217 neurology & neurosurgeryJournal of Affective Disorders
researchProduct

Is assessment of depression equivalent for migrants of different cultural backgrounds? Results from the German population-based Gutenberg Health Stud…

2018

BACKGROUND Bearing in mind the multicultural background of a national population, little is known about the measurement invariance across different cultures or ethnicities of frequently used screeners for depression. For this reason, the main objective of the current study is to assess the measurement invariance of the Patient Health Questionnaire (PHQ-9) across groups with different migration backgrounds. METHODS We provided psychometric analyses (descriptive statistics at item and scale level, reliability analysis, exploratory [EFA] and confirmatory factor analyses [CFA]) comparing a native population with first- and second-generation migrants of the German population-based Gutenberg Heal…

AdultMalemedicine.medical_specialtyCulturePopulationEthnic groupEmigrants and ImmigrantsPatient Health Questionnaire03 medical and health sciencesMental distress0302 clinical medicineGermanyEpidemiologymedicineHumansMeasurement invariance030212 general & internal medicineeducationAgedDepressive Disordereducation.field_of_studyDescriptive statisticsDepressionReproducibility of ResultsMiddle Aged030227 psychiatryPatient Health QuestionnairePsychiatry and Mental healthClinical PsychologyScale (social sciences)FemalePsychologyClinical psychologyDepression and Anxiety
researchProduct

What are depressive symptoms in acutely ill patients with schizophrenia spectrum disorder?

2014

AbstractBackground:Aim was to examine depressive symptoms in acutely ill schizophrenia patients on a single symptom basis and to evaluate their relationship with positive, negative and general psychopathological symptoms.Methods:Two hundred and seventy-eight patients suffering from a schizophrenia spectrum disorder were analysed within a naturalistic study by the German Research Network on Schizophrenia. Using the Calgary Depression Scale for Schizophrenia (CDSS) depressive symptoms were examined and the Positive and Negative Syndrome Scale (PANSS) was applied to assess positive, negative and general symptoms. Correlation and factor analyses were calculated to detect the underlying structur…

AdultMalemedicine.medical_specialtyDepression scaleMedizinSeverity of Illness Index03 medical and health sciences0302 clinical medicineGermanyPrevalencemedicineHumans030212 general & internal medicinePsychiatryDepression (differential diagnoses)Depressive symptomsPsychiatric Status Rating ScalesPositive and Negative Syndrome ScaleDepressionGeneral symptomsMiddle Agedmedicine.disease030227 psychiatry3. Good healthHospitalizationAffectPsychiatry and Mental healthResearch DesignSchizophreniaAcute DiseaseGuiltSchizophreniaFemaleSchizophrenic PsychologyFactor Analysis StatisticalPsychologyPsychopathologyClinical psychologySchizophrenia spectrumEuropean Psychiatry
researchProduct

High cognitive reserve in bipolar disorders as a moderator of neurocognitive impairment

2017

BackgroundCognitive reserve (CR) reflects the capacity of the brain to endure neuropathology, minimize clinical manifestations and successfully complete cognitive tasks. The present study aims to determine whether high CR may constitute a moderator of cognitive functioning in bipolar disorder (BD).MethodsOne hundred and two patients with BD and 32 healthy controls were enrolled. All patients met DSM-IV criteria for I or II BD and were euthymic (YMRS ≤ 6 and HDRS ≤ 8) during a 6-month period. All participants were tested with a comprehensive neuropsychological battery, and a Cerebral Reserve Score (CRS) was estimated. Subjects with a CRS below the group median were classified as having low C…

AdultMalemedicine.medical_specialtyElementary cognitive taskBipolar DisorderBipolar disorderCognitive reserveNeuropsychological TestsAudiologyYoung Adult03 medical and health sciences0302 clinical medicineCognitive ReservemedicineHumansVerbal fluency testCognitive skillBipolar disorderPsychiatryNeurocognitionCognitive reserveCalifornia Verbal Learning TestBipolar disorder Cognitive heterogeneity Cognitive reserve NeurocognitionMiddle Agedmedicine.diseaseCyclothymic Disorder030227 psychiatryDiagnostic and Statistical Manual of Mental DisordersPsychiatry and Mental healthClinical PsychologyCross-Sectional StudiesCognitive remediation therapyFemaleCuesVerbal memoryCognition DisordersPsychologyNeurocognitive030217 neurology & neurosurgeryCognitive heterogeneityJournal of Affective Disorders
researchProduct

Neural correlates of an attentional bias to health-threatening stimuli in individuals with pathological health anxiety

2017

Background: An attentional bias to health-threat stimuli is assumed to represent the primary pathogenetic factor for the development and maintenance of pathological health anxiety (PHA; formerly termed “hypochondriasis”). However, little is known about the neural basis of this attentional bias in individuals with PHA.Methods: A group of patients with PHA, a group of depressed patients and a healthy control group completed an emotional Stroop task with health-threat (body symptom and illness) words and neutral control words while undergoing functional MRI.Results: We included 33 patients with PHA, 28 depressed patients and 31 controls in our analyses. As reflected in reaction times, patients…

AdultMalemedicine.medical_specialtyEmotionschemical and pharmacologic phenomenaAudiologyAttentional biasBrain mappingAmygdalaArousalAttentional Bias03 medical and health sciences0302 clinical medicineddc:150Reaction TimemedicineHumansPharmacology (medical)PsychiatryBiological PsychiatryAnterior cingulate cortexBrain MappingBrainmedicine.diseaseAnxiety DisordersMagnetic Resonance Imaging030227 psychiatryPsychiatry and Mental healthmedicine.anatomical_structureReadingStroop TestVisual PerceptionAnxietyFemalemedicine.symptomPsychologyAttitude to Health030217 neurology & neurosurgeryAnxiety disorderResearch PaperStroop effectJournal of Psychiatry & Neuroscience
researchProduct

Impact of the WHO depression guideline on patient care by psychiatrists: a randomized controlled trial.

2008

AbstractBackgroundScientific literature reviews aim to summarize the state of knowledge and published empirical evidence. In contrast, medical guidelines are intervention tools that aim to improve physician behaviour and patient outcome. They can have positive effects, but they can also have negative effects. Their effects must be tested by research.MethodsIn a randomized controlled trial, 103 psychiatrists in private practice were either provided with the WHO depression guideline only (information group), or provided with the WHO depression guideline and trained for one day in this guideline (intervention group), or left uninformed (control group). They then treated a total of 497 patients…

AdultMalemedicine.medical_specialtyEvidence-based practiceInservice TrainingMirtazapineMianserinAntidepressive Agents TricyclicWorld Health Organizationlaw.invention03 medical and health sciences0302 clinical medicineContinuing medical educationRandomized controlled triallawGermanymedicineHumans030212 general & internal medicinePsychiatryAgedPsychiatryDepressive Disorderbusiness.industryEvidence-based medicineGuidelineMiddle AgedMental health030227 psychiatryPsychiatry and Mental healthAffectPrivate practicePractice Guidelines as TopicPhysical therapyFemalebusinessPsychosocialEuropean psychiatry : the journal of the Association of European Psychiatrists
researchProduct